4'-SUBSTITUTED NUCLEOSIDES AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF FOR PREPARING DRUG FOR TREATMENT OF HEPATITIS C VIRUS (HCV)-MEDIATED DISEASES Russian patent published in 2008 - IPC A61K31/7068 A61K31/7076 A61P31/14 C07H19/67 C07H19/73 C07H19/167 C07H19/173 

Abstract RU 2322989 C2

FIELD: organic chemistry, medicine, virology, pharmacy.

SUBSTANCE: invention relates to using 4'-substituted nucleosides of the formula (I): wherein R means hydrogen atom; R1 means alkyl possibly substituted with hydroxyl, and alkenyl, alkynyl, alkoxy, cyano or azido group; R2 means hydrogen atom or hydroxyl; R3 and R4 mean hydrogen atom, hydroxyl, alkoxy or halogen atom under condition that at least one radical among R3 and R4 means hydrogen atom; B means 9-purinyl residue of the formula (B1): wherein R5 means hydrogen atom; R6 means hydroxyl or -NHR8; R7 means hydrogen atom; R8 means hydrogen atom or phenylcarbonyl; or B means 1-pyrimidinyl residue of the formula (B2): wherein Z means oxygen atom (O); R10 means hydroxyl or -NHR8; R11 means hydrogen atom; R8 means a value given above. Also, invention relates to pharmaceutically acceptable salts of the compounds used for preparing a drug for treatment of diseases mediated by hepatitis C virus (HCV). Also, invention relates to a pharmaceutical composition for preparing a drug used in treatment of diseases mediated by hepatitis C virus (HCV), and to using this pharmaceutical composition for preparing a drug for treatment of diseases mediated by hepatitis C virus (HCV).

EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.

7 cl, 9 sch, 3 ex

Similar patents RU2322989C2

Title Year Author Number
β-D-2ʹ-DEOXY-2ʹ-α-FLUORO-2ʹ-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR TREATMENT OF DISEASES CAUSED BY HCV 2016
  • Sommadossi, Jean-Pierre
  • Moussa, Adel
RU2764767C2
HCV-ACTIVE 4'-ASIDONUCLEOSIDES 2011
  • Ma Khan
  • Sarma Keshab
  • Smit Dehvid Bernard
RU2556991C2
MODIFIED 2- AND 3-NUCLEOSIDES AND USE THEREOF TO PRODUCE MEDICINAL AGENT, HAVING HEPATITIS C INHIBITING ACTIVITY 2003
  • Sommadossi Zhan-P'Er
  • La Kolla Paolo
  • Storer Richard
  • Gosselin Zhil'
RU2437892C2
MODIFIED 2'- AND 3'-NUCLEOSIDES AND USE THEREOF FOR PREPARING DRUG FOR TREATING FLAVIVIRIDAE INFECTIONS 2011
  • Sommadossi Zhan-P'Er
  • La Kolla Paolo
  • Storer Richard
  • Gosselin Zhil'
RU2483075C2
PROMEDICINES OF MODIFIED 2'- AND 3'-NUCLEOSIDES FOR TREATMENT OF FLAVIVIRIDAE INFECTIONS 2003
  • Sommadossi Zhan-P'Er
  • La Kolla Paolo
  • Storer Richard
  • Gosselin Zhil'
RU2366661C2
ALKYL2-{[(2R,3S,5R)-5-(4-AMINO-2-OXO-2H-PYRIMIDINE-1-YL)- -HYDROXY- TETRAHYDRO-FURAN-2-YLMETHOXY]-PHENOXY-PHOSPHORYLAMINO}-PROPTONATES, NUCLEOSIDE INHIBITORS OF RNA-POLYMERASE HCV NS5B, METHODS FOR PRODUCING AND USING THEM 2013
  • Ivashchenko Aleksandr Vasil'Evich
RU2534613C2
NUCLEOTIDES INCLUDING N-[(S)-1-CYCLOBUTOXYCARBONYL]PHOSPHORAMIDATE FRAGMENT, THEIR ANALOGS AND THEIR APPLICATION 2017
  • Aleksandr Vasilevich Ivashchenko
  • Mitkin Oleg Dmitrievich
RU2659388C1
PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDES 2010
  • Jonkers Tim Kh'Jugo Marija
  • Rabuasson P'Er Zhan-Mari Bernar
  • Vandik Koehn
  • Pel'Kman Mikaehl'
  • Sund Bengt Krist'Jan
  • Vekhling Khorst Jurgen
  • Pasush Pin'Ju Pedro Manuehl
  • Vinkvist Anna
  • Nil'Sson Karl Magnus
RU2553656C2
NUCLEOSIDES WITH ACTIVITY AGAINST HEPATITIS B VIRUS 1999
  • Gosselehn Zhill'
  • Ehmbash Zhan-Lui
  • Sommadossi Zhan-P'Er
  • Skinazi Rehjmond F.
RU2237479C2
METHOD OF PREPARING CIS-NUCLEOSIDE ANALOGS, THEIR SALTS AND ESTERS 1994
  • Tarek S.Mansur
  • Kollin Ivans
  • Khaolun Dzhin
  • Arskhad M.Siddiku
  • Allan Kh.L.Tse
RU2139870C1

RU 2 322 989 C2

Authors

Devos Rene Robert

Khobbs Kristofer Dzhon

Tszjan Vehn'Zhun

Martin Dzhozef Armstrong

Merrett Dzhon Kherbert

Nadzhera Izabel

Shimma Nobuo

Tsukuda Takuo

Dates

2008-04-27Published

2002-06-07Filed